Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 4 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
Front Immunol. 2023 Jun 28;14:1161869. doi: 10.3389/fimmu.2023.1161869. eCollection 2023.
Front Immunol. 2023.
PMID: 37449205
Free PMC article.
A potent antibiotic-loaded bone-cement implant against staphylococcal bone infections.
Ghosh S, Sinha M, Samanta R, Sadhasivam S, Bhattacharyya A, Nandy A, Saini S, Tandon N, Singh H, Gupta S, Chauhan A, Aavula KK, Varghese SS, Shi P, Ghosh S, Garg MK, Saha T, Padhye A, Ghosh S, Jang HL, Sengupta S.
Ghosh S, et al. Among authors: padhye a.
Nat Biomed Eng. 2022 Oct;6(10):1180-1195. doi: 10.1038/s41551-022-00950-x. Epub 2022 Oct 13.
Nat Biomed Eng. 2022.
PMID: 36229662
Free PMC article.
Item in Clipboard
Development, characterization, and applications of multi-material stereolithography bioprinting.
Grigoryan B, Sazer DW, Avila A, Albritton JL, Padhye A, Ta AH, Greenfield PT, Gibbons DL, Miller JS.
Grigoryan B, et al. Among authors: padhye a.
Sci Rep. 2021 Feb 4;11(1):3171. doi: 10.1038/s41598-021-82102-w.
Sci Rep. 2021.
PMID: 33542283
Free PMC article.
Item in Clipboard
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.
Padhye A, Konen JM, Rodriguez BL, Fradette JJ, Ochieng JK, Diao L, Wang J, Lu W, Solis LS, Batra H, Raso MG, Peoples MD, Minelli R, Carugo A, Bristow CA, Gibbons DL.
Padhye A, et al.
JCI Insight. 2021 Sep 8;6(17):e148392. doi: 10.1172/jci.insight.148392.
JCI Insight. 2021.
PMID: 34309585
Free PMC article.
Item in Clipboard
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.
Peng DH, Rodriguez BL, Diao L, Gaudreau PO, Padhye A, Konen JM, Ochieng JK, Class CA, Fradette JJ, Gibson L, Chen L, Wang J, Byers LA, Gibbons DL.
Peng DH, et al. Among authors: padhye a.
Nat Commun. 2021 May 10;12(1):2606. doi: 10.1038/s41467-021-22875-w.
Nat Commun. 2021.
PMID: 33972557
Free PMC article.
Item in Clipboard
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC.
Konen JM, Rodriguez BL, Padhye A, Ochieng JK, Gibson L, Diao L, Fowlkes NW, Fradette JJ, Peng DH, Cardnell RJ, Kovacs JJ, Wang J, Byers LA, Gibbons DL.
Konen JM, et al. Among authors: padhye a.
Cancer Res. 2021 Mar 1;81(5):1398-1412. doi: 10.1158/0008-5472.CAN-20-1895. Epub 2021 Jan 5.
Cancer Res. 2021.
PMID: 33402388
Free PMC article.
Item in Clipboard
A novel ex vivo tumor system identifies Src-mediated invasion and metastasis in mesenchymal tumor cells in non-small cell lung cancer.
Padhye A, Ungewiss C, Fradette JJ, Rodriguez BL, Albritton JL, Miller JS, Gibbons DL.
Padhye A, et al.
Sci Rep. 2019 Mar 20;9(1):4819. doi: 10.1038/s41598-019-41301-2.
Sci Rep. 2019.
PMID: 30894630
Free PMC article.
Item in Clipboard
Cite
Cite